Clinical trial
A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's…
NCT00193492 · SCRI Development Innovations, LLC, Other · Completed
Key facts
| NCT number | NCT00193492 |
|---|---|
| Title | A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma |
| Official title | Rituximab +/- Bevacizumab in the Treatment of Patients With Follicular Non-Hodgkin's Lymphoma: A Randomized, Phase II Trial |
| Lead sponsor | SCRI Development Innovations, LLC, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Follicular |
| Intervention type | Drug |
| Interventions | Bevacizumab, Rituximab |
| Enrollment | 60 |
| Start date | Sep 1, 2005 |
| Primary completion | Mar 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 5, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: